Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Clinical Pathology"
DOI: 10.1136/jclinpath-2017-204327
Abstract: Activating mutations in KRAS and NRAS genes in patients with colorectal cancer (CRC) are associated with a lack of response to treatment with anti-epidermal growth factor receptor (EGFR) therapies. Mutations in these genes are thought…
read more here.
Keywords:
treatment;
ras mutations;
intratumorous heterogeneity;
colorectal tumour ... See more keywords